Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions

AGRAWAL S, 2004, Solid state characterization of rifampicin samples and its biopharmaceutic relevance, Eur. J. Pharm. Sci, 22, 127, 10.1016/j.ejps.2004.02.011

ARAÚJO A. A. S, 2003, Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms, Int. J. Pharm, 260, 303, 10.1016/S0378-5173(03)00288-6

BACCHI A, 1998, Comprehensive study on structure-activity relationships of rifamycins: Discussion of molecular and crystal structure and spectroscopic and spectroscopic and thermochemical properties of rifamycin, J. Med. Chem, 41, 2319, 10.1021/jm970791o

BUJNOWSKI K, 2003, Rifamycin antibiotics-new compounds and synthetic methods: Part 1: Study of the reaction of 3-formylrifamycin SV with primary alkylamines or ammonia, Tetrahedron, 59, 1885, 10.1016/S0040-4020(03)00184-4

CARVALHO W. S, 2007, Diagnóstico de resistência do Mycobacterium tuberculosis à rifampicina utilizando-se da reação em cadeia da polimerase, Rev. Bras. Ciênc. Farm, 43, 31, 10.1590/S1516-93322007000100004

CIDES L.C.D, 2006, Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isotermal conditions, J. Therm. Anal. Calorim, 84, 441, 10.1007/s10973-005-7131-8

FORD J.L, 1989, 108

GIRON D, 1998, Contribution of thermal methods and related techniques to the rational development of pharmaceuticals-Part 1, Pharm. Sci. Technol. Today, 1, 191, 10.1016/S1461-5347(98)00046-7

GIRON D, 1998, Contribution of thermal methods and related techniques to the rational development of pharmaceuticals-Part 2, Pharm. Sci. Technol. Today, 6, 262, 10.1016/S1461-5347(98)00066-2

HENWOOD S.Q, 2000, Solubility and dissolution properties of generic rifampicin raw materials, Drug Dev. Ind. Pharm, 26, 403, 10.1081/DDC-100101246

MATOS J.R, 2009, Aspectos gerais relativos ao desenvolvimento farmacotécnico de medicamento: análise térmica aplicada a fármacos e medicamentos, 32

OZAWA T, 1965, A new method of analyzing thermogravimetric data, Bull. Chem. Soc. Jpn, 38, 1881, 10.1246/bcsj.38.1881

PANCHAGNULA R, 2004, Biopharmaceutic and pharmacokinetics aspects of variable bioavailability of rifampicin, Int. J. Pharm, 271, 1, 10.1016/j.ijpharm.2003.11.031

PARISE FILHO R, 2004, Thermoanalytical characterization of potentially schistosomicide polymeric derivatives, J. Therm. Anal. Calorim, 75, 487, 10.1023/B:JTAN.0000027137.43662.de

PELIZZA G, 1977, Polymorphism of rifampicin, Farmaco (Sci), 32, 471

ROUQUEROL J, 2007, Developments in nomenclature, 5, 21

SALTINI C, 2006, Chemotherapy and diagnosis of tuberculosis, Resp. Med, 100, 2085, 10.1016/j.rmed.2006.09.015

SINGH S, 2001, A critical review of probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem, Int. J. Pharm, 228, 5, 10.1016/S0378-5173(01)00754-2

VENKATARAM S, 1995, Differential scanning calorimetry as a quick scanning technique for solid state stability studies, Drug Dev. Ind. Pharm, 21, 847, 10.3109/03639049509026649

2006

2007, 5

ZHANG Y, 2005, The magic bullets and tuberculosis drug targets, Annu. Rev. Pharmacol. Toxicol, 45, 529, 10.1146/annurev.pharmtox.45.120403.100120